Skip to main content

Drugs

Ausgabe 1/2019

Inhalt (11 Artikel)

Leading Article

Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer

Maxime Chénard-Poirier , Elizabeth C. Smyth

Leading Article

Recent Developments in Male Contraception

Arthi Thirumalai, Stephanie T. Page

Open Access Review Article

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives

Aura D. Herrera-Martínez, Johannes Hofland, Leo J. Hofland, Tessa Brabander, Ferry A. L. M. Eskens, María A. Gálvez Moreno, Raúl M. Luque, Justo P. Castaño, Wouter W. de Herder, Richard A. Feelders

Review Article

Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice

Carla Greenbaum, Dana VanBuecken, Sandra Lord

Review Article

Targeting Angiogenesis in Colorectal Carcinoma

Anthony Lopez, Kazuto Harada, Maria Vasilakopoulou, Namita Shanbhag, Jaffer A. Ajani

Review Article

Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease

Samarth Siddharth Patel, Mohammad Shadab Siddiqui

Open Access AdisInsight Report

Revefenacin: First Global Approval

Young-A Heo

AdisInsight Report

Lorlatinib: First Global Approval

Yahiya Y. Syed

AdisInsight Report

Emapalumab: First Global Approval

Zaina T. Al-Salama

Open Access Correction

Correction to: Moxetumomab Pasudotox: First Global Approval

Sohita Dhillon

Open Access Correction

Correction to: Ivosidenib: First Global Approval

Sohita Dhillon

Aktuelle Ausgaben